Development of B12-deficiency anemia in a patient with type 2 diabetes mellitus in the treatment of metformin

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access


The article describes the case of development of B12-deficiency anemia in a 68-year-old patient with type 2 diabetes mellitus after 4 years of metformin therapy. A brief review of literature data on metformin-induced B12-deficiency anemia and its correction methods is presented. Patients who take metformin for a long time are recommended to study the concentration of vitamin B12 and, at its reduction, to carry out preventive maintenance therapy with vitamin B12 to avoid the development of anemia and/or polyneuropathy. Particular attention in patients with type 2 diabetes should be given early diagnosis of polyneuropathy, which may be associated with the use of metformin, so that, at the first signs of it, an adequate treatment should be prescribed.

Full Text

Restricted Access


Copyright (c) 2017 Eco-Vector

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: № 01975 от 30.12.1992.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies